Tag: Absci
Absci lines up a 150-patient test of its generative antibody
Absci's STORYLINE trial would test a generative-AI-designed antibody in about 150 endometriosis patients starting mid-2027.
Absci's STORYLINE trial would test a generative-AI-designed antibody in about 150 endometriosis patients starting mid-2027.